Ascendis Pharma A/S (ASND)

Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $7.94 billion. The enterprise value is $8.16 billion.

Market Cap	7.94B
Enterprise Value	8.16B

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

ASND has 59.76 million shares outstanding. The number of shares has increased by 1.70% in one year.

Current Share Class	n/a
Shares Outstanding	59.76M
Shares Change (YoY)	+1.70%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	83.33%
Float	59.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.87
Forward PS	18.89
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	22.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.16

Current Ratio	1.16
Quick Ratio	0.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.88

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-20.07%
Return on Capital (ROIC)	-30.75%
Revenue Per Employee	$415,458
Profits Per Employee	-$541,158
Employee Count	879
Asset Turnover	0.33
Inventory Turnover	0.22

Taxes

In the past 12 months, ASND has paid $10.65 million in taxes.

Income Tax	10.65M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.31% in the last 52 weeks. The beta is 0.65, so ASND's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+28.31%
50-Day Moving Average	131.84
200-Day Moving Average	136.45
Relative Strength Index (RSI)	56.74
Average Volume (20 Days)	534,359

Short Selling Information

Short Interest	3.57M
Short Previous Month	3.41M
Short % of Shares Out	8.03%
Short % of Float	n/a
Short Ratio (days to cover)	8.50

Income Statement

In the last 12 months, ASND had revenue of $365.19 million and -$475.68 million in losses. Loss per share was -$8.33.

Revenue	365.19M
Gross Profit	309.76M
Operating Income	-352.17M
Pretax Income	-539.03M
Net Income	-475.68M
EBITDA	-345.64M
EBIT	-352.17M
Loss Per Share	-$8.33

Balance Sheet

The company has $697.65 million in cash and $879.61 million in debt, giving a net cash position of -$181.96 million or -$3.04 per share.

Cash & Cash Equivalents	697.65M
Total Debt	879.61M
Net Cash	-181.96M
Net Cash Per Share	-$3.04
Equity (Book Value)	-108.54M
Book Value Per Share	-1.82
Working Capital	150.88M

Cash Flow

In the last 12 months, operating cash flow was -$291.65 million and capital expenditures -$1.05 million, giving a free cash flow of -$276.09 million.

Operating Cash Flow	-291.65M
Capital Expenditures	-1.05M
Free Cash Flow	-276.09M
FCF Per Share	-$4.62

Margins

Gross margin is 84.82%, with operating and profit margins of -96.44% and -130.26%.

Gross Margin	84.82%
Operating Margin	-96.44%
Pretax Margin	-127.34%
Profit Margin	-130.26%
EBITDA Margin	-94.65%
EBIT Margin	-96.44%
FCF Margin	-129.43%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.70%
Shareholder Yield	-1.70%
Earnings Yield	-5.96%
FCF Yield	-3.46%

Analyst Forecast

The average price target for ASND is $191.77, which is 44.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$191.77
Price Target Difference	44.41%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	51.25%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASND has an Altman Z-Score of -0.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.37
Piotroski F-Score	4